Analysis of loss of chromosome 10q, DMBT1 homozygous deletions, and PTEN mutations in oligodendrogliomas

Journal of Neurosurgery

Volumn 97, Issue 6, 2002, Pages 1397-1401

  Sanson, Marc ^a,b,c,d,e   Leuraud, Pascal ^a,b,c,d,e   Aguirre Cruz, Lucinda ^a,b,c,d,e   He, Jié ^a,b,c,d,e   Marie, Yannick ^a,b,c,d,e   Cartalat Carel, Stéphanie ^a,b,c,d,e   Mokhtari, Karima ^a,b,c,d,e   Duffau, Hugues ^a,b,c,d,e   Delattre, Jean Yves ^a,b,c,d,e   Hoang Xuan, Khê ^a,b,c,d,e  

^a INSERM   (France)

^b Service de Neurologie 2 Mazarin   (France)

^c Lab de Neuropathologie R Escourolle   (France)

^d Service de Neurochirurgie   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Chromosome 10; Oligodendroglioma; Prognostic marker; Tumor suppressor gene loss of heterozygosity

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; PROTEIN DMBT1; UNCLASSIFIED DRUG;

ADULT; ANAPLASTIC CARCINOMA; ARTICLE; CANCER SURVIVAL; CHROMOSOME 10Q; CHROMOSOME DELETION; CHROMOSOME LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE MUTATION; GENETIC ANALYSIS; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; OLIGODENDROGLIA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR GROWTH;

EID: 0036894629     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2002.97.6.1397     Document Type: Article

References (26)

1. Bello MJ, Leone PE, Vaquero J, et al: Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors. Int J Cancer 64:207-210, 1995
2. Cairncross G, Macdonald D, Ludwin S, et al: Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 12:2013-2021, 1994
3. Caimcross JG, Ueki K, Zlatescu MC, et al: Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90:1473-1479, 1998
4. Coons SW, Johnson PC, Scheithauer BW, et al: Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79:1381-1393, 1997
5. Daumas-Duport C, Varlet P, Tucker ML, et al: Oligodendrogliomas: Part 1: Patterns of growth, histological diagnosis, clinical and imaging correlations: A study of 153 cases. J Neurooncol 34:37-59, 1997
6. Duerr EM, Rollbrocker B, Hayashi Y, et al: PTEN mutations in gliomas and glioneural tumors. Oncogene 16:2259-2264, 1998
7. Fujimoto M, Fults DW, Thomas GA, et al: Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme. Genomics 4:210-214, 1989
8. Fujisawa H, Kurrer M, Reis RM, et al: Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter. Am J Pathol 155:387-394, 1999
9. Jeuken JW, Nelen MR, Vermeer H, et al: PTEN mutation analysis in two genetic subtypes of high-grade oligodendroglial tumors. PTEN is only occasionally mutated in one of the two genetic subtypes. Cancer Genet Cytogenet 119:42-47, 2000
10. Kleihues P, Cavenee WK: Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press, 2000
11. Kraus JA, Koopmann J, Kaskel P, et al: Shared allelic losses on chromosomes lp and 19q suggest a common origin of oligoden-droglioma and oligoastrocytoma. J Neuropathol Exp Neurol 54:91-95, 1995
12. Li J, Yen C, Liaw D, et al: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 275:1943-1947, 1997
13. Lin H, Bondy ML, Langford LA, et al: Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: Relationship to prognostic significance. Clin Cancer Res 4:2447-2454, 1998
14. Maier D, Comparone D, Taylor E, et al: New deletion in low-grade oligodendroglioma at the glioblastoma suppressor locus on chromosome 10q25-26. Oncogene 15:997-1000, 1997
15. Maier D, Zhang Z, Taylor E, et al: Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas. Oncogene 16:3331-3335, 1998
16. Mollenhauer J, Herbertz S, Holmskov U, et al: DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. Cancer Res 60:1704-1710, 2000
17. Mollenhauer J, Holmskov U, Wiemann S, et al: The genomic structure of the DMBT1 gene: Evidence for a region with susceptibility to genomic instability. Oncogene 18:6233-6240, 1999
18. Mollenhauer J, Wiemann S, Scheurlen W, et al: DMBT1, a new member of the SRCR supeffamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumors. Nat Genet 17:32-39, 1997
19. Rasheed BK, Stenzel TT, McLendon RE, et al: PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 57:4187-4190, 1997
20. Reifenberger J, Reifenberger G, Liu L, et al: Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 145:1175-1190, 1994
21. Sasaki H, Zlatescu MC, Betensky RA, et al: PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis. Am J Pathol 159:359-367, 2001
22. Smith JS, Alderete B, Minn Y, et al: Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 18:4144-4152, 1999
23. Somerville RP, Shoshan Y, Eng C, et al: Molecular analysis of two putative tumor suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiforme disease progression. Oncogene 17:1755-1757, 1998
24. Steck PA, Lin H, Langford LA, et al: Functional and molecular analyses of 10q deletions in human gliomas. Genes Chromosomes Cancer 24:135-143, 1999
25. Steck PA, Pershouse MA, Jasser SA, et al: Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356-362, 1997
26. Zhou XP, Li YJ, Hoang-Xuan K, et al: Mutational analysis of the PTEN gene in gliomas: Molecular and pathological correlations. Int J Cancer 84:150-154, 1999